INSTRUCCIONES OFICIALES

Tirzepatide60 mg

Instrucciones originales de producto.

Modelo
M9
Formato
vial
Producto
Tirzepatide
Potencia declarada
60 mg

Esta página reúne la documentación oficial disponible para la presentación identificada. Consulte siempre el nombre, el código y el formato del envase.

Documento oficialDocumento original · Inglés

Producto

Tirzepatide

Potencia declarada

60 mg

Modelo

M9

Formato

vial

Documento técnico en su idioma original. Se conservan la redacción, las cifras y las advertencias de la documentación oficial.

Original product illustration: tirzepatide-vial-60-mg
Referencia visual incluida en el documento original
Contenido original

Metabolic Care M9

Tirzepatide 60 mg 
Vial

This product is a multi-dose vial containing a ready-to-use injectable solution of Tirzepatide. It is intended for institutional and professional use.

Ready-to-use sterile solution
For subcutaneous injection

Institutional use only

Composition and Format

  • Active compound: Tirzepatide

  • Total content: 60 mg

  • Total volume: 2,4 ml

  • Form: Ready-to-use injectable solution

  • Presentation: Multi-dose vial

  • Route of administration: Subcutaneous injection

  • Dosing format: 4 doses of 15 mg (0.60 ml per dose)

  • Included accessories: 1 prefilled pen, 3 sterile needles

Dosage Information

When used as a 15 mg weekly regimen (0.60 ml), each vial provides 4 doses.

  • Total content: 60 mg in 2,4 ml

  • Weekly regimen: 15 mg per dose (0.60 ml)

  • Number of doses: 4 doses per vial or as directed by a healthcare professional

  • Frequency: Use once per week or as directed by a healthcare professional

Intended Use

This product is intended exclusively for use by licensed institutions and qualified healthcare professionals. It is not intended for direct sale to the public and should be used in accordance with institutional protocols and applicable regulations.

Instructions for Use

  1. Use once per week as directed.

  2. Withdraw the prescribed dose from the vial using a sterile syringe.

  3. Inject slowly into the subcutaneous tissue (abdomen, thigh, or upper arm).

  4. Use only sterile needles and syringes.

  5. Dispose of the needle safely after each use.

  6. Handle the vial in accordance with institutional protocols.

Storage and Handling

  • Store refrigerated at 2–8 °C.

  • Do not freeze.

  • Protect from inappropriate storage conditions.

Safety Information

  • Refer to the leaflet before use.

  • Use only with sterile needles and syringes.

  • Use only as directed by a healthcare professional.

  • Keep out of reach of children.

  • Do not use if the solution is cloudy or contains particles.

Regulatory and Disclaimer

This information is provided for institutional and informational purposes only.
True North Labs does not provide medical advice or therapeutic recommendations.
Always follow applicable regulations, institutional protocols, and professional guidance.

Distribution Information

Distributed by: True North Labs

Verifique que el documento corresponda al nombre, código y presentación del etiquetado físico. Esta consulta no es una recomendación médica ni una confirmación de autorizaciones regulatorias.